A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Public ClinicalTrials.gov record NCT07218146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer
Study identification
- NCT ID
- NCT07218146
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Industry
- Enrollment
- 480 participants
Conditions and interventions
Conditions
Interventions
- Investigator's Choice of Therapy Drug
- ZL-1310 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2025
- Primary completion
- Jun 29, 2028
- Completion
- Nov 29, 2028
- Last update posted
- Apr 22, 2026
2025 – 2028
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Zai Lab Site 02030 | New Haven | Connecticut | 06519 | Recruiting |
| Zai Lab Site 02045 | Clermont | Florida | 34711 | Recruiting |
| Zai Lab Site 02031 | Orange City | Florida | 32763 | Recruiting |
| Zai Lab Site 02020 | Rockledge | Florida | 32955 | Recruiting |
| Zai Lab Site 02026 | Sarasota | Florida | 34232 | Recruiting |
| Zai Lab Site 02021 | Peoria | Illinois | 61615 | Recruiting |
| Zai Lab Site 02049 | Peoria | Illinois | 61637 | Recruiting |
| Zai Lab Site 02041 | Louisville | Kentucky | 40202 | Recruiting |
| Zai Lab Site 02003 | Bethesda | Maryland | 20817 | Recruiting |
| Zai Lab Site 02022 | Silver Spring | Maryland | 20904 | Recruiting |
| Zai Lab Site 02023 | Columbia | Missouri | 65201 | Recruiting |
| Zai Lab Site 02009 | St Louis | Missouri | 63128 | Recruiting |
| Zai Lab Site 02040 | The Bronx | New York | 10461 | Recruiting |
| Zai Lab Site 02024 | Cleveland | Ohio | 44106 | Recruiting |
| Zai Lab Site 02035 | Broomall | Pennsylvania | 19008 | Recruiting |
| Zai Lab Site 02019 | Media | Pennsylvania | 19063 | Recruiting |
| Zai Lab Site 02008 | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| Zai Lab Site 02029 | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| Zai Lab Site 02036 | Nashville | Tennessee | 37203 | Recruiting |
| Zai Lab Site 02025 | Austin | Texas | 78745 | Recruiting |
| Zai Lab Site 02025 | Odessa | Texas | 79761 | Recruiting |
| Zai Lab Site 02006 | Fairfax | Virginia | 22031 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07218146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07218146 live on ClinicalTrials.gov.